Contravisory Investment Management’s Insulet PODD Stock Holding History

Contravisory Investment Management’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,952	Closed	-$839K	–	415
2025 Q4	$839K	Sell	2,952 -112	-4%	-$35K	0.17%	94
2025 Q3	$946K	Sell	3,064 -110	-3%	-$34.5K	0.18%	72
2025 Q2	$997K	Sell	3,174 -12	-0.4%	-$3.46K	0.2%	67
2025 Q1	$837K	Buy	3,186 +1,073	+51%	+$290K	0.18%	87
2024 Q4	$552K	Buy	+2,113	New	+$532K	0.12%	118
2018 Q1	–	Sell	-15	Closed	-$1K	–	429
2017 Q4	$1K	Hold	15	–	–	﹤0.01%	384
2017 Q3	$1K	Buy	+15	New	+$819	﹤0.01%	433

Other funds holding PODD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Contravisory Investment Management's PODD Position: Q1 2026 in Review

Contravisory Investment Management sold out of Insulet (PODD) in Q1 2026, closing a stake of 2,952 shares — an estimated $839K sold.

Contravisory Investment Management first reported a position in PODD in Q3 2017 and held it in 7 quarters. The position peaked at $997K in Q2 2025. 787 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

Contravisory Investment Management reported no remaining Insulet position as of Q1 2026 after selling out during the quarter.
Contravisory Investment Management sold 2,952 Insulet shares in Q1 2026, an estimated $839K.
Contravisory Investment Management first reported a position in Insulet in Q3 2017 and held it in 7 quarters.
Contravisory Investment Management's Insulet position peaked at $997K in Q2 2025.
787 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Contravisory Investment Management's 13F filing for Q1 2026, filed 20 Apr 2026.